Transamerica Financial Advisors’s Collegium Pharmaceutical COLL Stock Holding History

Transamerica Financial Advisors’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.16K	Buy	+32	New	+$1.09K	﹤0.01%	1457

Other funds holding COLL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Transamerica Financial Advisors's COLL Position: Q2 2026 in Review

Transamerica Financial Advisors opened a new position in Collegium Pharmaceutical (COLL) in Q2 2026: 32 shares worth $1.16K. The stake represents ﹤0.01% of the portfolio and ranks #1457 among its holdings.

279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

Transamerica Financial Advisors held 32 shares of Collegium Pharmaceutical worth $1.16K as of Q2 2026.
Collegium Pharmaceutical was a new Transamerica Financial Advisors position in Q2 2026.
Collegium Pharmaceutical made up ﹤0.01% of Transamerica Financial Advisors's portfolio in Q2 2026, its #1457 holding.
279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Transamerica Financial Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.